Frazier Life Sciences Management L.P. boosted its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 33.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,401,704 shares of the biopharmaceutical company’s stock after purchasing an additional […]
FourWorld Capital Management LLC lessened its stake in Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma comprises approximately 1.8% of FourWorld Capital Management LLC’s investment portfolio, making the […]
FourWorld Capital Management LLC reduced its position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma […]
Forefront Analytics LLC purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 19,982 shares of the technology company’s stock, valued at approximately $117,000. A number of other large investors have also made changes to their positions in COGT. AJOVista LLC acquired […]
Point72 Asset Management L.P. raised its position in Morphic Holding, Inc. (NASDAQ:MORF – Free Report) by 83.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,591,000 shares of the company’s stock after purchasing an additional 2,086,617 shares during the quarter. Point72 […]